000 01269 a2200337 4500
005 20250515044523.0
264 0 _c20061109
008 200611s 0 0 eng d
022 _a1474-547X
024 7 _a10.1016/S0140-6736(06)69615-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aIoannidis, John P A
245 0 0 _aIndirect comparisons: the mesh and mess of clinical trials.
_h[electronic resource]
260 _bLancet (London, England)
_cOct 2006
300 _a1470-2 p.
_bdigital
500 _aPublication Type: Comment; Journal Article
650 0 4 _aAcquired Immunodeficiency Syndrome
_xdrug therapy
650 0 4 _aAdult
650 0 4 _aAnti-Bacterial Agents
_xtherapeutic use
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aAntiretroviral Therapy, Highly Active
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xdrug therapy
650 0 4 _aChild, Preschool
650 0 4 _aClinical Trials as Topic
_xmethods
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aPyelonephritis
_xdrug therapy
650 0 4 _aStatistics as Topic
773 0 _tLancet (London, England)
_gvol. 368
_gno. 9546
_gp. 1470-2
856 4 0 _uhttps://doi.org/10.1016/S0140-6736(06)69615-3
_zAvailable from publisher's website
999 _c16645594
_d16645594